Abstract:This study examines in vivo the role and functional interrelationships of components regulating exit from the G1 resting phase into the DNA synthetic (S) phase of the cell cycle. Our approach made use of several key experimental attributes of the developing mouse lens, namely its strong dependence on pRb in maintenance of the postmitotic state, the down-regulation of cyclins D and E and up-regulation of the p57(KIP2) inhibitor in the postmitotic lens fiber cell compartment, and the ability to target transgene expression to this compartment. These attributes provide an ideal in vivo context in which to examine the consequences of forced cyclin expression and/or of loss of p57(KIP2) inhibitor function in a cellular compartment that permits an accurate quantitation of cellular proliferation and apoptosis rates in situ. Here, we demonstrate that, despite substantial overlap in cyclin transgene expression levels, D-type and E cyclins exhibited clear functional differences in promoting entry into S phase. In general, forced expression of the D-type cyclins was more efficient than cyclin E in driving lens fiber cells into S phase. In the case of cyclins D1 and D2, ectopic proliferation required their enhanced nuclear localization through CDK4 coexpression. High nuclear levels of cyclin E and CDK2, while not sufficient to promote efficient exit from G1, did act synergistically with ectopic cyclin D/CDK4. The functional differences between D-type and E cyclins was most evident in the p57(KIP2)-deficient lens wherein cyclin D overexpression induced a rate of proliferation equivalent to that of the pRb null lens, while overexpression of cyclin E did not increase the rate of proliferation over that induced by the loss of p57(KIP2) function. These in vivo analyses provide strong biological support for the prevailing view that the antecedent actions of cyclin D/CDK4 act cooperatively with cyclin E/CDK2 and antagonistically with p57(KIP2) to regulate the G1/S transition in a cell type highly dependent upon pRb.

Discriminative SKP2 Interactions with CDK-Cyclin Complexes Support a Cyclin A-Specific Role in p27KIP1 Degradation

Skp2-Cyclin A Interaction Is Necessary For Mitotic Entry and Maintenance of Diploidy

Dynamic anticipation by Cdk2/Cyclin A-bound p27 mediates signal integration in cell cycle regulation

Ubiquitylation and Proteasomal Degradation of the P21(Cip1), P27(Kip1) and P57(Kip2) Cdk Inhibitors

Cks1: Structure, Emerging Roles and Implications in Multiple Cancers

Ubiquitylation and Proteasomal Degradation of the P21cip1, P27kip1and P57kip2cdk Inhibitors

Cyclin D- and E-Dependent Kinases and the P57(Kip2) Inhibitor: Cooperative Interactions in Vivo

P57(Kip2), A Structurally Distinct Member of the P21(Cip1) Cdk Inhibitor Family, is A Candidate Tumor-Suppressor Gene

A Novel Cycline/cyclina-Cdk Inhibitor Targets P27(kip1) Degradation, Cell Cycle Progression and Cell Survival: Implications in Cancer Therapy.

PTEN regulates the ubiquitin-dependent degradation of the CDK inhibitor p27KIP1 through the ubiquitin E3 ligase SCFSKP2

Structural studies with inhibitors of the cell cycle regulatory kinase cyclin-dependent protein kinase 2.

Cooperation between the <i>Cdk</i> inhibitors <i>p27<sup>KIP1</sup></i> and <i>p57<sup>KIP2</sup></i> in the control of tissue growth and development

Apc/C-Cdh1 Targets Brain-Specific Kinase 2 (Brsk2) For Degradation Via The Ubiquitin-Proteasome Pathway

Ubiquitin ligases: cell-cycle control and cancer

CDK Inhibitors: Cell Cycle Regulators and Beyond

Cooperation Between The Cdk Inhibitors P27(Kip1) And P57(Kip2) In The Control Of Tissue Growth And Development

Functional Versatility of the CDK Inhibitor p57Kip2

CDK5-cyclin B1 regulates mitotic fidelity

Highlighting the Major Role of Cyclin C in Cyclin-Dependent Kinase 8 Activity through Molecular Dynamics Simulations

Slower CDK4 and faster CDK2 activation in the cell cycle

New functional activities for the p21 family of CDK inhibitors.